Outsourcing Pharma
MARCH 25, 2021
A survey by the Pistoia Alliance indicates most professionals believe the tech can accelerate R&D, but companies are stymied by a skills gap and data bias.
pharmaphorum
MARCH 23, 2021
“Gamification” – adding game-like elements into non-game or real-world settings – has become a popular concept in the pharmaceutical, healthcare, and event industries, especially as virtual engagement becomes more common during COVID-19. However, it is proving more than a mere buzzword. With diverse applications and approaches, it is quickly becoming a promising tool for patient adherence, chronic disease management, preventive medicine, rehabilitation, and paediatric care, as well as for medica
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Druggist
MARCH 23, 2021
Ibuprofen is one of the most common drugs purchased over the counter in the UK. Ibuprofen prescribing decreased significantly in recent years due to the NHS strategy to minimise issuing of medicines that are available over the counter. In recent months, ibuprofen’s price went up significantly, with many shops and pharmacies being out of stock of ‘cheap’ ibuprofen.
Pharma Marketing Network
MARCH 23, 2021
Innovation During COVID-19 Fact Sheet. We compiled a fact sheet on innovations in digital publishing that sparked due to the pandemic and have since been soaring. . Get your complimentary copy of "The Publishing Industry: The Soar of Innovation During COVID-19 Fact Sheet". Name *. First. Last. Company Email *. Lead Source * Web Active Prospecting Sales Ad-Label Advertising - Offline Advertising - Online Advertising - Online - FocalPoint Advertising - Online - Mobile Advertising - Online - Trend
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Outsourcing Pharma
MARCH 23, 2021
The companyâs Prime-Control Technology is designed to help study teams expand their subject enrollment beyond the reach of their clinical trial sites.
pharmaphorum
MARCH 25, 2021
In the year since the UK went into its first lockdown to limit the spread of COVID-19 the country’s health service has undergone an unprecedented digital transformation. . The NHS quickly scrambled to reduce face-to-face contact between patients and healthcare professionals, and manage demand for services that would soon be overstretched by dealing with the pandemic.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
Policy Prescription
MARCH 26, 2021
Would you vote for legislation to lower drug prices that would lead to a five percent reduction in pharmaceutical innovation — yet simultaneously create a health system in which all Americans could afford the prescription drugs they need? That’s compared to the one we have now where a quarter of Americans struggle with drug prices. I would vote for it.
Outsourcing Pharma
MARCH 22, 2021
A leader from oncologist-founded trial tech specialists COTA shares how advanced data analysis can benefit cancer researchers and patients alike.
pharmaphorum
MARCH 23, 2021
Novartis’ radioligand therapy Lu-PSMA-617 has met its target in prostate cancer, as its $2.1 billion acquisition of specialist pharma Endocyte looks to have been justified. . The big Swiss pharma added this drug to its pipeline after it swooped for Endocyte and so far it looks like a good piece of business, with potential blockbuster sales predicted for the drug if it makes it to market.
Pharma Times
MARCH 22, 2021
Recurrent pericarditis is an autoinflammatory cardiovascular disease
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Pharma Mirror
MARCH 26, 2021
One of the best gifts you can give to another person is a beautiful smile. Though it costs you nothing, it goes a long way in adding to others and you. It typically has a favourable effect on others, attracts people to you, and makes you approachable and likeable. A smile is very important. It is a part of your dressing and personality. Without a smile, you are incomplete, no matter how expensively and gorgeously dressed you are.
Outsourcing Pharma
MARCH 23, 2021
Health Union offers patients dealing with a range of conditions ways to connect with valuable information, research opportunities and each other online.
pharmaphorum
MARCH 22, 2021
For the past year, life science companies around the world worked at breakneck speed to develop and manufacture safe and effective treatments to respond to the COVID-19 pandemic. The scramble to produce vaccines and therapeutics and the challenges of getting these products to poorer countries underscores the growing importance of local pharma manufacturers for these emerging markets. .
McCreadie Group
MARCH 23, 2021
March 2021 | Jennifer Drabing, Senior Marketing Communications Manager McCreadie Group is proud to work with Reveles Clinical Services and privileged to sit down with its CEO and founder, R’Kes Starling, to discuss decentralized clinical trials. This blog, the first part of the interview series with R’Kes, focuses on the future of virtual trails, the.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Pharma Mirror
MARCH 23, 2021
The Japanese pharmaceutical market is preparing for renewed international growth and partnering. In response, CPhI Japan has opened a two-month long virtual event to meet demand from international pharma. Informa introduced CPhI Japan Connect – a new virtual platform for global professionals looking to grow pharma business in Japan – specifically to help its international audiences continue conversations, identify leads, and build new partnerships while international travel remains restricted.
Outsourcing Pharma
MARCH 24, 2021
The company reports that its patient-centric virtual study technology currently is in use in more than 60 ongoing trials in over 40 different countries.
pharmaphorum
MARCH 24, 2021
Pfizer has begun clinical development of an antiviral pill against COVID-19, which could be prescribed to patients at the first sign of infection. The company was the first to get a vaccine approved against the disease with BioNTech and is now aiming to make a pill that could prevent it escalating once patients are infected. Being able to manage coronavirus infections and prevent hospitalisations and death would have huge benefits for wider society as well as patients after more than a year of l
Pharma Times
MARCH 26, 2021
Marketing authorisation application is seeking approval for advanced urothelial cancer
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Med Ed 101
MARCH 24, 2021
Akathisia is one of the most common symptoms associated with extrapyramidal symptoms (EPS) due to antipsychotics. There are a few different medications that we can use for the management of akathisia. Here’s a good summary of akathisia. Prior to even considering medications for akathisia management, we need to remember that some antipsychotics carry a higher […].
Outsourcing Pharma
MARCH 24, 2021
Two experts from CRO Phastar talk about how trial professionals face new, ever-changing challenges regarding collecting and disseminating patient data.
pharmaphorum
MARCH 22, 2021
AstraZeneca is mourning the loss of one of its top scientists after eminent cancer researcher José Baselga passed away at the age of just 61. . Baselga was a heavyweight in oncology research, pursuing a career that saw him serve as physician-in-chief at Memorial Sloan Kettering Cancer Centre in the US and also hold the position as president of the American Association of Cancer Research (AACR) before joining AZ to lead the drugmaker’s cancer R&D in January 2019.
Pharma Times
MARCH 25, 2021
Lead ‘Allosteric PLK1’ asset will initially target brain cancer
Druggist
MARCH 25, 2021
Cerelle and Cerazette are two brands of daily progestogen-only pill (POP), also known as mini-pill. In recent years prescribing of Cerazette in NHS decreased, in place of other brands, including Cerelle. Today I will discuss the reasons for this change and review different aspects of Cerelle vs Cerazette use. . Summary of the post: Cerelle vs Cerazette: are they the same?
Outsourcing Pharma
MARCH 25, 2021
A US courtâs recent decision to find in favor of Sanofi and invalidate Amgen's broad antibody patent claims has biotech manufacturers concerned about how to preserve their IP.
pharmaphorum
MARCH 25, 2021
There is a pressing need for a joined-up cancer strategy to reverse the impact of the COVID-19 pandemic, according to a new report from the UK’s pharma industry. The Association of the British Pharmaceutical Industry ( ABPI) report said that the UK must be more ambitious with its cancer strategy if it is to compete with the leading nations across Europe.
Pharma Times
MARCH 25, 2021
Study compared women who continued on relugolix combination therapy with women who discontinued treatment
pharmaphorum
MARCH 26, 2021
There’s a new kid on the block among companies using artificial intelligence in drug discovery, after 1910 Genetics launched today with $26 million in financing. The Cambridge, Massachusetts-based startup claims it is the only biotech launched so far that will use AI to design both small-molecule drugs and protein therapeutics, coupled with automated biological testing to speed up drug development and reduce costs.
pharmaphorum
MARCH 24, 2021
TEAM 4 Travis is an advocacy group with one objective – to ensure it doesn’t take an autopsy to diagnose isolated congenital asplenia. As part of our Patient Insights series, founder Allison Bones tells us why she is determined to stop history repeating itself. When Travis Bones died just days after his fourth birthday, his family had no idea he had a rare birth defect that had left him without a spleen – and extremely vulnerable to infection.
pharmaphorum
MARCH 22, 2021
Getting a diagnosis is often the biggest challenge facing a rare disease patient in the UK. We take a look at efforts from charities, the government and digital innovators to boost awareness of rare conditions among GPs and make the clinical pathway smoother for patients. There are more than 150,000 people living with a rare neurological condition in the UK, which taken together means that these conditions aren’t actually that rare at all – and that’s just for one slice of the wider rare disease
pharmaphorum
MARCH 26, 2021
Regeneron has posted findings from a large trial of its COVID-19 antibody cocktail showing the therapy reduced risk of hospitalisation or death by 70%. The US pharma said that the results were a landmark as they “conclusively” demonstrated that REGEN-COV (casirivimab+imdevimab) can significantly reduce death in an outpatient setting. Data from the phase 3 trial will also be used to convert an Emergence Use Authorisation into a permanent licence, Regeneron said.
pharmaphorum
MARCH 25, 2021
Boehringer Ingelheim invested €3.7 billion on R&D last year, the highest spend in its history, as it mobilised its scientists to seek out new therapies for COVID-19. . Not all those efforts have been successful. Boehringer abandoned BI 764198, an inhibitor of TRPC6 in phase 2 for acute respiratory distress syndrome (ARDS) in patients hospitalised for COVID-19 earlier this month.
pharmaphorum
MARCH 23, 2021
AstraZeneca has been rebuked by a US health authority after a trial monitoring board said data published from a large study of its COVID-19 vaccine may be out of date and may not give a representative view of its efficacy. The company’s share price ticked down after the statement on Monday from the US National Institute for Allergy and Infectious Diseases (NIAID).
pharmaphorum
MARCH 23, 2021
Roche has stopped dosing in a phase 3 trial of tominersen, a potential Huntington’s disease (HD) drug developed with Ionis, after a pre-planned review by independent experts. . The companies had been working on tominersen since December 2017, when Roche licensed it in from Ionis. There were high expectations for tominersen, which the companies hoped would be the first drug to treat the underlying cause of the disease, which leads to devastating neurological degeneration.
Expert insights. Personalized for you.
145 
Let's personalize your content